Thanks! You've successfully subscribed to the BONEZONE®/OMTEC® Monthly eNewsletter!

Please take a moment to tell us more about yourself and help us keep unwanted emails out of your inbox.

Choose one or more mailing lists:
BONEZONE/OMTEC Monthly eNewsletter
OMTEC Conference Updates
Advertising/Sponsorship Opportunities
Exhibiting Opportunities
* Indicates a required field.

Antimicrobial Coatings: The Research and Regulatory Perspective

When: Wednesday, June 12 | 10:00 am - 10:45 am 
Where: Coatings Tech Center
Level: All
Participant Type: Research & Development, Product Development, Regulatory/Clinical Affairs, Quality Control, Manufacturing

 

Description

Coatings have long been considered an avenue for infection prevention in orthopedic procedures. These coatings, some of which utilize silver, have largely not been commercialized because regulators seek greater evidence of their safety, creating a long, expensive road for device companies. Announcements in the last half of 2018 and early 2019 indicate that companies continue to push to get them on the market and that productive conversations are taking place with regulators. This session begins with a history of antimicrobial coatings followed by a look at recent research and technology and an audience Q&A.

Attendee Takeaways

  • Learn the applications for orthopedic antimicrobial coatings
  • Discover how research demonstrates the success of antimicrobial coatings
  • Gain insight into regulatory pathways for antimicrobial coatings

Speakers

Thomas J. Webster, Ph.D., is Department Chair of Chemical Engineering at Northeastern University. He also serves as Director of Nanomedicine Laboratories and has completed extensive studies on the use of nanophase materials in medicine. His recent honors include the Zheijang 1000 Talent Program, 2016; the International Materials Research Chinese Academy of Science Lee-Hsun Lecture Award and appointment to the 2016 International College of Fellows, Biomaterials Science and Engineering. He is also the 1st Past President of the U.S. Society for Biomaterials. Dr. Webster holds a B.S. in chemical engineering from the University of Pittsburgh and a Master’s and Ph.D. in Biomedical Engineering from Rensselaer Polytechnic Institute.

Karl Richter is Owner of RFH BioTek, the North American partner of Bio-Gate AG. Mr. Richter is responsible for Business Development of Bio-Gate’s technologies in North America, including its PVD/CVD Plasma coatings for medical implants, antimicrobial coatings and antimicrobial testing and R&D services. His responsibilities include developing distribution partners, establishing commercial terms, overseeing account management and giving technical presentations. He received a degree in Systems Design Engineering from the University of Waterloo, Canada.